Treatment of Telangiectasia: Comparison of Sclerosing Agents

Carlin, Marie C.; Ratz, John Louis

doi:10.1111/j.1524-4725.1987.tb02429.x

Cited by 57 publications

(32 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…All sclerosants, excluding placebo, had similar efficacy. The lowest incidence of adverse events and greatest patient comfort was noted with POL . As mentioned above, STS has at least twice the potency of POL .…”

Section: Discussionmentioning

confidence: 78%

Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial of Polidocanol and Hypertonic Saline

Peterson

Goldman

Weiß

et al. 2012

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 78%

Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial of Polidocanol and Hypertonic Saline

Peterson

Goldman

Weiß

et al. 2012

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

“…Estes últimos são mais efetivos para os vasos, porém, são mais agressivos para a pele 11 . A glicose hipertônica constitui-se em um dos esclerosantes mais importantes 12 …”

Section: Discussionunclassified

Tratamento combinado da cirurgia de varizes com a escleroterapia de telangiectasias dos membros inferiores no mesmo ato

Gaspar

Medeiros

2006

J. vasc. bras.

View full text Add to dashboard Cite

53 ResumoObjetivos: A escleroterapia por método químico é o tratamento mais tradicional para eliminar as telangiectasias. Há varias décadas, é realizada em consultório, mas com alto índice de abandono devido ao seu caráter prolongado, doloroso e, por isso, pouco eficaz. Uma grande proporção destes pacientes apresenta também insuficiência de tributárias, ou seja, veias varicosas com indicação de fleboextração e que serão submetidas à cirurgia. O objetivo deste trabalho é descrever a opção de tratamento combinado da cirurgia de varizes com a escleroterapia das telangiectasias no mesmo ato.Métodos: De janeiro de 1998 a março de 2002, 213 pacientes (426 membros inferiores) foram submetidos ao tratamento das telangiectasias por meio de injeção de glicose hipertônica durante a cirurgia de varizes.Resultados: Mais de 90% dos pacientes relataram altos índices de satisfação estética. A escleroterapia complementar foi necessária em 165 pacientes, para atingir plena satisfação estética durante o seguimento. Não foram constatados casos de tromboflebites superficiais, nem de trombose venosa profunda. Também não houve relatos de complicações graves. Em 10% dos casos, foram necessárias pequenas drenagens de microtrombos residuais. O índice de manchas hipercrômicas não ultrapassou 3%. Apenas um paciente desenvolveu uma pequena úlcera no dorso do pé (0,2%), que cicatrizou espontaneamente.Conclusões: O tratamento combinado da cirurgia de varizes com a escleroterapia das telangiectasias dos membros inferiores é uma alternativa para os pacientes que desejam um resultado mais rápido e indolor. As sessões múltiplas com injeção de glicose hipertônica são uma opção segura e eficaz.Palavras-chave: Cirurgia ambulatorial, escleroterapia, insuficiên-cia venosa, varizes. AbstractObjectives: Chemical sclerotherapy is the most traditional treatment to eliminate telangiectasias. For several decades, it has been carried out in the office, although it has a high index of treatment dropout for being a painful, long and, therefore, little efficient treatment. Most of these patients also present insufficient varicose veins, which require phlebectomy and are candidates for surgery. The aim of this paper is to describe the combined treatment including varicose vein surgery and sclerotherapy for telangiectasias at the same procedure.Methods: From January 1998 to March 2002, 213 patients (426 lower limbs) with telangiectasias were treated by means of hypertonic glucose infusion during the varicose vein surgery.Results: More than 90% of the patients reported high indices of aesthetic satisfaction. The complementary sclerotherapy was necessary in 165 patients to have full aesthetic satisfaction during follow-up. Any cases of superficial thrombophlebitis or of deep venous thrombosis were reported. There were no serious complications either. In 10% of cases, small drainage of residual microthrombus was necessary. The index of hyperchromic spots did not exceed 3%. Only one patient developed a small ulcer in the back of the foot (0.2%), which spontaneously h...

show abstract

“…It can be effective in saphenofemoral incompetence, when surgical treatment is contraindicated. Relief of symptoms occurs in up to 85% of patients with varicose and telangiectatic veins [36]. Modern sclerotherapy treatment has been shown to be simple and safe, with low risk of significant side effects and efficacy comparable to surgical procedures in appropriately selected patients.…”

Section: Skin Substitutesmentioning

confidence: 99%

Chronic venous insufficiency

Schainfeld

2003

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Patients with chronic venous insufficiency arguably have been relegated to a standard of care that is lower than that for those with the more appealing entity of peripheral arterial disease. Fortunately, the collaboration of an expanding group of clinicians (including cardiologists and vascular medicine specialists) with vascular surgeons is stimulating a renewed interest in the management of patients afflicted with venous disease. With the increased level of awareness of venous disease, technologic advances undoubtedly will augment the armamentarium available for the treatment of patients with chronic venous insufficiency. The focus on the prevention of venous thromboembolic complications has been advanced greatly, as witnessed by the growth of new pharmacologic agents, such as heparinoids, antiplatelet agents, direct thrombin inhibitors, thrombolytics, and pentasaccharides. In addition, the more aggressive strategy of intervening in acute deep venous obstruction by using thrombolytic agents and adjunctive mechanical thrombectomy devices potentially may obviate the future sequelae of chronic venous insufficiency. The tremendous growth of endovascular techniques in recent years has revolutionized the management of problems due to acute and chronic arterial obstructive disease. The application of these techniques in the future may have a similar impact in improving the clinical outcomes of patients with chronic venous disease and potentially, if proven safe and efficacious in clinical trials, may lower the threshold for intervention to an earlier disease stage. Similarly, with the advent of endovascular and endoscopic techniques, surgical procedures will also continue to evolve, with these procedures complementing one another, as opposed to serving as surrogates, which traditionally has been the case.

show abstract

Treatment of Telangiectasia: Comparison of Sclerosing Agents

Cited by 57 publications

References 13 publications

Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial of Polidocanol and Hypertonic Saline

Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial of Polidocanol and Hypertonic Saline

Tratamento combinado da cirurgia de varizes com a escleroterapia de telangiectasias dos membros inferiores no mesmo ato

Chronic venous insufficiency

Contact Info

Product

Resources

About